↓ Skip to main content

PLOS

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses

Overview of attention for article published in PLOS ONE, August 2014
Altmetric Badge

Mentioned by

twitter
6 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
63 Mendeley
Title
Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
Published in
PLOS ONE, August 2014
DOI 10.1371/journal.pone.0103446
Pubmed ID
Authors

Kathryn L. Hopkins, Fatima Laher, Kennedy Otwombe, Gavin Churchyard, Linda-Gail Bekker, Stephen DeRosa, Maphoshane Nchabeleng, Koleka Mlisana, James Kublin, Glenda Gray

Abstract

Phambili, the Merck (MRK)-Adenovirus Type 5 (Ad5) HIV-1 gag/pol/nef subtype B vaccine study, conducted in South Africa, suspended enrollment and vaccination when companion study, Step, was found non-efficacious. Although the vaccine did not prevent HIV-1 infection or lower viral-load setpoint, immune responses recognized clades B and C HIV-1 subtypes. We investigated predictors of the vaccine-induced antigen-specific immune responses.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 2%
Unknown 62 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 14%
Student > Master 8 13%
Student > Bachelor 7 11%
Professor > Associate Professor 6 10%
Student > Doctoral Student 4 6%
Other 13 21%
Unknown 16 25%
Readers by discipline Count As %
Medicine and Dentistry 20 32%
Nursing and Health Professions 6 10%
Immunology and Microbiology 6 10%
Agricultural and Biological Sciences 5 8%
Biochemistry, Genetics and Molecular Biology 3 5%
Other 5 8%
Unknown 18 29%